chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pertinent Medical History: "RHEUMATOID ARTHRITIS"; Drug Reactions/Allergies: 'LATEX, LEVOFLOXACIN, FENTANYL, ASPIRIN, EGGS, MOLD, CEPHALASPORINS, OTHER UNKNOWN ALLERGIES; Drug Reactions/Allergies: 'LATEX, LEVOFLOXACIN, FENTANYL, ASPIRIN, EGGS, MOLD, CEPHALASPORINS, OTHER UNKNOWN ALLERGIES; Drug Reactions/Allergies: 'LATEX, LEVOFLOXACIN, FENTANYL, ASPIRIN, EGGS, MOLD, CEPHALASPORINS, OTHER UNKNOWN ALLERGIES; Drug Reactions/Allergies: 'LATEX, LEVOFLOXACIN, FENTANYL, ASPIRIN, EGGS, MOLD, CEPHALASPORINS, OTHER UNKNOWN ALLERGIES; Drug Reactions/Allergies: 'LATEX, LEVOFLOXACIN, FENTANYL, ASPIRIN, EGGS, MOLD, CEPHALASPORINS, OTHER UNKNOWN ALLERGIES; the patient bad negative titers for Mumps; Route of Administration: "INTRAMUSCULAR"; This spontaneous report as received from a registered nurse refers to a female patient reported to currently be 30 years old. Her concomitant medications were unknown by the reporter.   In 1988, the patient was vaccinated with suspect measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). In 1989, she received another measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II); both were administered intramuscularly (incorrect route of product administration) for the prevention of measles, mumps, and rubella (concentration, administered doses, frequency of vaccination scheme, anatomical location of vaccination, lot numbers, and expiration dates were unknown).   Other suspect therapies, administered to the patient on unspecified dates, included levofloxacin, fentanyl, aspirin, and unspecified cephalosporins; to which the patient experienced reactions/allergies (drug hypersensitivity) on unspecified dates. The action taken with these products was not reported.   On unspecified dates, the patient experienced allergies to latex (rubber sensitivity), eggs (food allergy), mold (mycotic allergy), other unknown allergies (multiple allergies), and rheumatoid arthritis; her outcome from these events was not reported.   On 10-MAR-2020, the patient sought medical attention by visiting the physician's office for blood work that showed that she had negative titers for mumps (antibody test negative) which she did not receive treatment for and was reported to be resolved.        The reporter's causality assessment between suspect products and the occurrence of the events was not provided.   Upon internal review, rheumatoid arthritis was considered to be a medically significant event.
Patient reported tingling down her left arm that began 1 week after vaccine administration. The symptoms progressed to radiating and throbbing pain down the left arm. Patient also reports numbness in her thumb and index finger.
On 10/26/22 at  6:15p.m. Patient stated that she started feeling " like my muscles shaking, so I assumed that it was a fever and I went home and took tylenol around 7:15p.m.-7:30p.m..On 10/27/22, "I felt tremors and took tylenol in the morning and went to work and later on that evening around 6:30p.m., I had a fever around 100.7 and then she took tylenol and went to sleep. On 10/28/22, I woke up with a Migraine and PMS'ing and stayed home and work and took excedrin migraine and one hour after that I took midol. I slept the majority of the day. On 1028/22 around 5:00p.m., I started feeling numbness in my left foot.On 10/29/22, my right leg started becoming numb up the leg. On 10/30/22 around 10:05p.m., I developed pin and needles and numbness in both legs and groin area and took an uber to the ER and was admitted and the numbness and loss of sensation has spread from legs to groin to lungs.
Pt noted one day of hematochezia with blood clots on morning on 5/4/21. Sxs limited to one day.  No further episodes of hematochezia. Experienced lower abdominal pain and seen in emergency department on 5/6/21- dx constipation Had GI consult on 5/17/21- suspected cause of hematochezia due to constipation
Pain in heart; very bad running nose; Period all messed up day and length and flow; Frequent migrane; This spontaneous case was reported by a consumer and describes the occurrence of ANGINA PECTORIS (Pain in heart), RHINORRHOEA (very bad running nose), MENSTRUAL DISORDER (Period all messed up day and length and flow) and MIGRAINE (Frequent migrane) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis ((7 years ago approximately)), Drug allergy (Ciprofloxacin), Drug allergy (Glycine-bactrim allergy), Drug allergy (Sulfa allergy), Fruit allergy (Lemons allergy) and Gluten sensitivity (Gluten sensitivity (Autoimmune disorder) (7 years ago approximately)(). Concomitant products included COLECALCIFEROL (VIT D3) and VITAMIN B12 NOS for an unknown indication.    On 07-May-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANGINA PECTORIS (Pain in heart), RHINORRHOEA (very bad running nose), MENSTRUAL DISORDER (Period all messed up day and length and flow) and MIGRAINE (Frequent migrane). At the time of the report, ANGINA PECTORIS (Pain in heart), RHINORRHOEA (very bad running nose), MENSTRUAL DISORDER (Period all messed up day and length and flow) and MIGRAINE (Frequent migrane) outcome was unknown.            No treatment informations were reported. Patient has been taking Echinacea for the past 4 years.   This case was linked to MOD-2021-363416 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Oct-2021: Follow up received contains significant information- Reporter information, Patient details, Events, concomitant medications, medical history updated.
Large indurated, erythematous painful area around injection site-5 smaller areas over upper arm. KEFLEX 500 mg BID x 7d.
Tinnitus, constant ringing in ears / white noise. Started on Feb. 16.
feeling clammy; sweaty; High fever of 105 degrees when I woke up the following morning. Fever persisted all day and night averaging around 103 degrees; Body aches; headache; chills; This is a spontaneous report from contactable consumer (patient) reported for herself that:  A 42-years-old female patient received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 09Apr2021 11:30 (Batch/Lot Number: ER8729) as DOSE 2, SINGLE for covid-19 immunization (Age at vaccination 42 years). Facility where the most recent COVID-19 vaccine was administered Information: Hospital The patient past medical history included Lupus from an unknown date and unknown if ongoing. There were no allergies to medications, food and other products. The concomitant medication was none. The patient previously treated with BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 20Mar2021 06:30 AM (Batch/Lot Number: ER2613) as DOSE 1, SINGLE for covid-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. The patient has not received other medications in two weeks. On 10Apr2021, the patient experienced High fever of 105 degrees when she woke up the following morning fever persisted all day and night averaging around 103 degrees. Body aches, headache and chills. After 48 hours after the shot on 11Apr2021 she woke up feeling clammy and sweaty for about 10 hours. The patient underwent lab tests and procedures which included body temperature: 105 (High fever of 105 degrees when I woke up the following morning) and  body temperature: 103 (Fever  persisted all day and night averaging  around 103 degrees) on 10Apr2021. No treatment was reported. The outcome for the event fever, Body aches, headache and chills recovered on unspecified date in 2021 and feeling clammy and sweaty recovered on 11Apr2021.  No follow-up attempts are needed. No further information is expected.
PATIENT SAID HE HAD ON HIS RIGHT ARM IN THE GENERAL AREA OF WHERE THE VACCINE WAS ADMINISTERED. UNSURE OF WHEN HE SAW HIS DOCTOR REGARDING THE REACTION, BUT HE SAID THE RASH STARTED A FEW DAYS AFTER GETTING THE VACCINE. HE SAID THE DR TOLD HIM TO TAKE BENADRYL OVER THE COUNTER AND THAT HELPED TO CLEAR THE RASH. HE ALSO HAD A PNEUMONIA SHOT A WEEK PRIOR TO THE SHINGLES VACCINE, BUT WAS UNSURE WHICH ONE HE RECEIVED.
had no sense of taste; had no sense of smell; This is a spontaneous report from a contactable consumer reporting for herself. A 22-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on 16Apr2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient stated that she had gotten her second dose of the Pfizer covid 19 vaccine 3 days ago, Friday and since then (16Apr2021) she had no sense of taste and smell. Wanted to know if this was normal. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
BACK PAIN; FEELS LIKE PASSING OUT; LEG PAIN; This spontaneous report received from a consumer concerned a 25 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lyme disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 08-APR-2021 15:30 for prophylactic vaccination. The batch no was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced back pain. On 08-APR-2021, the subject experienced leg pain. On 08-APR-2021, the subject experienced feels like passing out. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from back pain, and leg pain, and the outcome of feels like passing out was not reported. This report was non-serious.
196 patients received 0.25mL of Moderna Covid-19 Bivalent; No adverse Event; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Bivalent) and NO ADVERSE EVENT (No adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Bivalent) and NO ADVERSE EVENT (No adverse Event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Bivalent) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Bivalent).    No Concomitant medications were provided.  It was reported that 196 patients had received 0.25 ml of Bivalent Moderna vaccine.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live significant follow up: Added age group and updated narrative.
My (L) arm started to swell immediately. A little while later my face started swelling. I was coughing and wheezing (I felt short of breath).
01-17-2013 pt stated he had chills/fever 101.7, 01/18/13 101 with night sweats x couple of weeks. Pain at inject. site as well. 1/21/13 contacted office - Prednisone prescribed. 1/25/13 knees hot & burning. 1/26 (5th day Prednisone) tapered - down until 2/5. 02/03/2013 pt relates pains returned in shoulder, dull pain, weakness down arm into hand. 02/05/2013 pt reports slight weakness & dull pain in upper (L) arm / shoulder. 02/06/2013 reports weight from 164 down to 152, muscle aches & pains "stiffness" cannot weakness, feel awful. Continues with multiple complaints to this date of 02/21/2013.
Had immunizations on 7/18/05--DTap, Hib, Prevnar--developed a widespread fine papular erythematous rash (on 7/19) on trunk & neck not the arms or legs. No itch, fever (though did feel warm on 7/19), sore throat, otalgia, or irritability.  Some diarrhea (yellow, watery, no blood, no mucus) X 2 today only.  Some loss of appetite.  Seen today (7/20) diagnosed with a morbiliform rash ? cause ? viral ? allergic.
My first period proceeding the vaccine was 15 days late. I had another period of a seemingly normal cycle (28 days) and then I stopped having my period. My cycle is currently on 131 days, which is very unusual. My last period started Feb. 3rd, lasted through the 7th, according to my (menses) tracker, and I have not had a period since then. I am not on birth control, I have not taken any new medications nor am I on any form of birth control. All pregnancy tests at home as well as at the doctors office have returned negative.
2 days after receiving the vaccine, I started having chronic hiccups after dinner.  The hiccups became daily and progressively worse, starting earlier in the morning each day and lasting until I would go to bed.  They did not resolve for 14 days.  Dr  had seen me before for intractable hiccups, when he saw me this time he prescribed baclofen and amytriptyline.  Hiccups stopped the day after amytriptyline started
Facial swelling and tingling both cheeks and nose. Nausea, Chills, no fever, tiredness, joint pain, muscle pain, headache.  Stiff neck  on left side, same side as injection site.  Arm soreness at injection site
-No adverse event -Gave Monovalent for 3rd dose vs. Bivalent
2nd Pfizer COVID-19 vaccine administered on April 29th around 8:15 am, around 10 pm that day patient developed abdominal cramping and nausea with vomiting.  The vomiting continued through Monday May 3rd.  Patient reports stools were a loose for a few days but are formed now.  Nausea has resolved but patient continues to have per-umbilical abdominal cramping with decreased appetite.  Patient doesn't think he's lost any weight.  No body aches, no fever.
On 9/8/21 Client came to the came to the clinic to receive his covid vaccine, after answering all the questions on the consent form . The first dose of the Pfizer vaccine was To The client .  While the client was sitting for his 15 minutes monitoring he states "I think, I received a vaccine already" when The nurse asked what do you mean the client states "Like I said I think I received a vaccine already , but I do not remember which one I took!! when answering the questions on the consent form, The client denied receiving any vaccine previously .
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Nov-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment medication was provided by reporter.   This case was linked to MOD-2021-402935 (Patient Link).
It was my 2nd  Shingrix Shingles vaccine.   Dec 14th - Migraine headache 12/15-12/19 - Chills, fever, stomach ache, muscle ache, migraine headache 12/21 - 12/24 - Vertigo, heart racing, chest pressure 12/28 - present - skipping beats, fatigue, chest pressure
REDNESS/SWELLING OF UPPER RIGHT ARM. POSSIBLE FEVER (DID NOT TAKE ACTUAL TEMP). MALAISE. TALKING IN SLEEP.
Breakthrough case admission after 4 vaccines Pfizer 2/24/21 Lot# En6200 ; Pfizer 3/17/21 Lot# Er2613;  Pfizer 10/20/21 Lot# Ff2590;  Pfizer 7/21/22Lot# FJ4991
Was fine all day and then while watching TV, left arm and left leg lost ability to move. No other symptoms
My left armpit was swollen 2 days after receiving the booster and still to this day hasn't changed.
About 5 days after the 1st Moderna dosage shot, I noticed a rash and it was hot to the touch and  itchy.  I scratched it and it caused the rash to spread.  It was a raised rash and eventually grew to over 4 inches in diameter.  At that point, it was no longer itchy but became very painful.  It was so painful that my arm started to feel numb and I could hardly move it. The rash was also very hard. I went to urgent care on the evening of January 21 to see Dr. He determined it was cellulitis and prescribed Keflex and Bactrim each for 7 days.  After about 2-3 days of antibiotics I started to see the rash decrease in size, pain and hardness.
Information has been received from a consumer concerning her 17 year old daughter with no known drug allergies who in October 2007, was vaccinated with a first dose of GARDASIL. There was no concomitant medication. The patient's mother also mentioned how terrible GARDASIL had been in ruining her daughter's life. A few days after receiving the first shot, the patient fell into a deep depression. In January 2008 the patient received a second dose of GARDASIL and at that point the patient fell into an even deeper depression and began having seizures. In June 2008 the patient received a third dose of GARDASIL and apparently at that point she became a full blown epileptic. On an unspecified date the patient was hospitalized (length of stay and hospital demographics not provided); the patient sought unspecified medical attention. It was also reported that the patient has had brain surgery twice. At the time of the report, the patient had not recovered. No laboratory or diagnostic studies were performed. The health professional contacted during telephone follow-up could not supply the following information: dates of vaccination, dose number, lot number, date of event, recovery status, hospital name, and other healthcare provider name and contact information. The health professional stated that the GARDASIL vaccinations were in fact given at their office, but at earlier dates than reported by the consumer. The reporter considered the events "fell into deep depression", "became a full blown epileptic", "how terrible GARDASIL had been in ruining her daughter's life" and "began having seizures" to be disabling. Additional information has been requested.
Post-menopausal woman as of April of 2018. I had a four day menstrual cycle start Thursday April 22 (day after first vaccine) completing April 25.
received Boostrix intravenously by error; received on 2020 a Tdap vaccine (unknown brand)/received Boostrix intravenously by error; This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 64-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included Dtap vaccine (1st dose received in 2020 (Unknown brand)).   On 18th August 2021, the patient received the 2nd dose of Boostrix (intravenous). On 18th August 2021, unknown after receiving Boostrix, the patient experienced intramuscular formulation administered by other route and drug dose administration interval too short. On an unknown date, the outcome of the intramuscular formulation administered by other route and drug dose administration interval too short were unknown.  Additional details were provided are as follows: The patient received Boostrix intravenously by error which led to intramuscular formulation administered by other route. This was the patient's 2nd Dtap vaccine (Boostrix) earlier than the recommended interval, led to drug dose administration interval too long. No other information were provided. The reporter consented to follow-up via a email.
pt dx w/GBS 2-3wk p/vax;12NOV96 middle back pain;severe h/a;15NOV tingling & numbness in hands & arms;inc pain w/elevated BP (reading taken @ home);16NOV inc back pain, inc h/a;went to ER dx w/back sprain;18NOV facial paralysis;adm to hosp
Site sore and some tenderness at injection site.  Pain using arm.  Not severe.  Assured by employee health it was normal.  Returned to employee health on 3 subsequent occasions within the year and on third visit was instructed to follow up with my physician.  An MRI was done and revealed a 3 cm calcified hematoma and localized inflammation at the injection site.  This limits mobility and is very painful to palpation and any pressure.  It is yet undetermined how to treat.  I was referred to orthopedic who was unsure how to treat and have now been referred to a hand arm specialist.
Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.            No Concomitant and Treatment information reported.
Muscle spasms in same arm immediately after shot was given. Muscle spasms lasted a day and a half but have subsided. However now having muscle spasms in right leg.
Initially felt pain (3 out of 10 to the touch) after a few hours and then increasing to level 4 by about the seventh hour after administration. (As an aside, this was definitely more painful than either Pfizer shot I took earlier this year.) Also started to feel a little fatigued before bed and that "not feeling quite right" feeling, typically for me with onset of mild fever. Difficulty sleeping, mostly due to arm pain.  In the following morning (about hour 14 after administration) noticed some very slight fever and body aches.  Currently am at Hour 20, and feel body aches, tiredness, arm pain, and mild fever.  Have held off taking either aspirin or acetaminophen to ensure good immune response.